Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prochymal in Steroid-Refractory Acute GVHD
NCT00366145Phase 3Completed
- Sponsor
- Mesoblast Ltd
- Start
- Aug 2006
- Primary completion
- Dec 2008
- Modality
- Stem Cell Therapies
- Countries
- 6
01
Overview
A Phase 3 trial of remestemcel-L-rknd in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Mesoblast Ltd. Started Aug 2006; status: completed.
02
Drugs
remestemcel-L-rknd
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT00366145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366145.